Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Semaglutide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05046873
What this trial is testing

A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 16
Not applicableActive Not RecruitingNCT05622045
What this trial is testing

Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)

Who this might be right for
ObesityBody Weight Changes
Loma Linda University 59
Not applicableStudy completedNCT07043361
What this trial is testing

Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels

Who this might be right for
Metabolic Disease
Hillel Yaffe Medical Center 5,300
Not applicableLooking for participantsNCT07589322
What this trial is testing

Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs

Who this might be right for
Obesity and Metabolic Syndrome
Tri-Service General Hospital (TSGH) 120
Testing effectiveness (Phase 2)Looking for participantsNCT03884075
What this trial is testing

Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

Who this might be right for
Non-Alcoholic SteatohepatitisNon-Alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 104
Large-scale testing (Phase 3)Study completedNCT05646706
What this trial is testing

A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)

Who this might be right for
Obesity
Novo Nordisk A/S 1,407
Early research (Phase 1)Study completedNCT03638778
What this trial is testing

Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 105
Not applicableStudy completedNCT05755360
What this trial is testing

DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 291
Not applicableStudy completedNCT03929679
What this trial is testing

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 218
Not applicableStudy completedNCT06215196
What this trial is testing

Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity

Who this might be right for
Overweight and Obesity
S.LAB (SOLOWAYS) 81
Large-scale testing (Phase 3)Not Yet RecruitingNCT06913023
What this trial is testing

Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus

Who this might be right for
Kidney Transplant Recipient
University Health Network, Toronto 37
Not applicableLooking for participantsNCT07621419
What this trial is testing

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

Who this might be right for
Diabetes Mellitus
Hospital Italiano de Buenos Aires 145
Testing effectiveness (Phase 2)Looking for participantsNCT06639464
What this trial is testing

Semaglutide for Helping Opioid Recovery

Who this might be right for
Opioid Use Disorder
Brigham and Women's Hospital 46
Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Early research (Phase 1)Study completedNCT06716307
What this trial is testing

A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity

Who this might be right for
Obesity
Novo Nordisk A/S 18
Not applicableLooking for participantsNCT07207148
What this trial is testing

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Who this might be right for
Multiple Sclerosis
Northwestern University 100
Large-scale testing (Phase 3)UnknownNCT05071417
What this trial is testing

Effect Of Semaglutide In Coronary Atheroma Plaque

Who this might be right for
Atheroscleroses, Coronary
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León 120
Very early researchUnknownNCT05249881
What this trial is testing

"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."

Who this might be right for
Diabetes Mellitus, Type 2Weight Change, Body
Aga Khan University 300
Testing effectiveness (Phase 2)Study completedNCT07819227
What this trial is testing

Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide

Who this might be right for
Chronic Kidney Disease
University Medical Center Groningen 41
Early research (Phase 1)Study completedNCT02079870
What this trial is testing

Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo

Who this might be right for
DiabetesMetabolism and Nutrition DisorderObesity
Novo Nordisk A/S 30
Next Page